Nana Bie
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 6
- Cancer Research top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 10
- Immunology top 5%
- Phagocytosis and Immune Regulation 3
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
- Molecular Biology top 10%
- Extracellular vesicles in disease 6
-
- Cancer Immunotherapy and Biomarkers 4
-
- Polysaccharides and Plant Cell Walls 3
- Journals
- Nature Communications (4 papers)Food & Function (4 papers)Molecular Pharmaceutics (2 papers)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Nana Bie
30 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Biomaterials 460
- Cancer Research 364
- Biomedical Engineering 980
- Immunology 430
- Molecular Biology 1.0k
Countries citing papers authored by Nana Bie
This map shows the geographic impact of Nana Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nana Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nana Bie more than expected).
Fields of papers citing papers by Nana Bie
This network shows the impact of papers produced by Nana Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nana Bie. The network helps show where Nana Bie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nana Bie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 70 | |
| 7 | 2023 | 31 | |
| 8 | 2023 | 10 | |
| 9 | Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblastsbreakdown → | 2022 | 200 |
| 10 | 2022 | 16 | |
| 11 | 2022 | 40 | |
| 12 | 2022 | 47 | |
| 13 | 2021 | 2 | |
| 14 | Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticlesbreakdown → | 2021 | 271 |
| 15 | 2021 | 104 | |
| 16 | 2019 | 189 | |
| 17 | Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapybreakdown → | 2019 | 679 |
| 18 | 2018 | 53 | |
| 19 | 2017 | 50 | |
| 20 | 2016 | 8 |
About Nana Bie
Nana Bie is a scholar working on Biomaterials, Immunology and Nutrition and Dietetics, having authored 31 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Extracellular vesicles in disease (6 papers), Nanoparticle-Based Drug Delivery (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Polysaccharides and Plant Cell Walls (3 papers), Phagocytosis and Immune Regulation (3 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Biomaterials (460 citations), Cancer Research (364 citations) and Biomedical Engineering (980 citations). Nana Bie has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Lu Gan, Tuying Yong, Xiangliang Yang, Xiaoqiong Zhang, Zhaohan Wei, Fuying Li, Jun Hu, Hongbo Zhang, Hélder A. Santos and Xuting Zhang. Their work appears in journals such as Nature Communications, Food & Function, Molecular Pharmaceutics, Journal of Functional Foods and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.